Algeria vs Dominican Republic: Access to anti-retroviral drugs, male
Algeria
68.0%
in 2024
Dominican Republic
68.0%
in 2024
Algeria rank
73rd
Dominican Republic rank
73rd
Access to anti-retroviral drugs, male over time
- Algeria
- Dominican Republic
How they compare
Algeria currently reports 68.0% against 68.0% in Dominican Republic, a difference of 0.0%.
The two have swapped places 3 times across 25 shared years of data; in 2000 it was Algeria ahead.
Algeria ranks 73rd and Dominican Republic ranks 73rd of 141 countries.
Algeria has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Algeria | Dominican Republic | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 13.3% | 4.5% | 8.8% | Algeria |
| 2010s | 42.6% | 30.8% | 11.8% | Algeria |
| 2020s | 69.6% | 59.2% | 10.4% | Algeria |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, male, Algeria or Dominican Republic?
- Algeria, at 68.0% against 68.0% in Dominican Republic as of 2024.
- What is the difference in access to anti-retroviral drugs, male between Algeria and Dominican Republic?
- 0.0%, with Algeria ahead.
- How many years of comparable data are there for Algeria and Dominican Republic?
- 25 years are reported by both, from 2000 to 2024.
- How do Algeria and Dominican Republic rank globally for access to anti-retroviral drugs, male?
- Algeria ranks 73rd and Dominican Republic ranks 73rd of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, male (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult males living with HIV who are receiving antiretroviral therapy.